Physician
Medical Faculty Associates, INC
Medical Faculty Associates, INC was paid $75.68M by Medicaid between Jan 2018 and Dec 2024, across 336 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.
33Billing provider infoMEDICAL FACULTY ASSOCIATES, INC
WASHINGTON, DC 20037
WASHINGTON, DC 20037
33aNPI1417990581assigned 06/14/2006
33bProvider typeDermatology Physician
28Total paid$75.68M
24GClaims1,486,160
24DCodes billed336
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dermatology Physician providers in District of Columbia
Rank by total paid#2 of 5
Median peer was paid$100K
This provider vs. median757×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 217,750 | $9.73M | |
| 2019 | 282,464 | $13.41M | |
| 2020 | 228,675 | $10.88M | |
| 2021 | 239,829 | $11.88M | |
| 2022 | 192,918 | $10.88M | |
| 2023 | 183,692 | $10.61M | |
| 2024incomplete | 140,832 | $8.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 139,112 | 127,427 | $11.88M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 130,250 | 117,837 | $9.90M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 178,511 | 161,138 | $9.63M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.1% | 58,018 | 52,363 | $6.12M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 6.0% | 118,809 | 42,432 | $4.55M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.2% | 62,787 | 57,859 | $3.20M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 3.2% | 24,225 | 10,746 | $2.44M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 23,068 | 21,373 | $1.76M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.0% | 29,446 | 11,406 | $1.54M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.9% | 13,841 | 12,399 | $1.42M |
| 99223 | Prolong inpt eval add15 m | 1.9% | 14,096 | 12,123 | $1.41M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 19,360 | 17,606 | $1.21M |
324 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 17,787 | $1.07M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.4% | 11,234 | $1.06M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.3% | 9,559 | $989K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 8,905 | $987K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 29,239 | $721K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16,800 | $691K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,615 | $579K |
| 77066 | Tomosynthesis, mammo | <1% | 4,292 | $514K |
| 71045 | Radiologic examination, chest; single view | <1% | 103,786 | $473K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 5,288 | $369K |
| 88307 | <1% | 5,002 | $367K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 5,259 | $356K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 5,032 | $343K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 4,587 | $335K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 10,711 | $328K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 11,273 | $316K |
| 95811 | <1% | 784 | $295K | |
| 77065 | Tomosynthesis, mammo | <1% | 3,295 | $295K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 62,484 | $290K |
| 20610 | <1% | 6,042 | $290K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 34,820 | $269K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 10,999 | $267K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 4,969 | $261K |
| 59025 | Fetal non-stress test | <1% | 6,999 | $255K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 5,686 | $242K |
| 97803 | <1% | 4,559 | $237K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,274 | $229K |
| 73564 | <1% | 9,828 | $223K | |
| 31231 | <1% | 1,620 | $213K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 2,884 | $213K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 3,896 | $207K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 6,126 | $206K |
| 76813 | <1% | 1,701 | $184K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 4,283 | $179K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,120 | $178K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 5,540 | $172K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 6,281 | $165K |
| 76830 | Ultrasound, transvaginal | <1% | 5,651 | $165K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 2,037 | $160K |
| 71250 | <1% | 3,945 | $148K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 5,076 | $147K |
| 76642 | <1% | 5,324 | $131K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 6,750 | $129K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,317 | $117K |
| 88342 | <1% | 4,307 | $115K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,219 | $110K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,161 | $110K |
| 95720 | <1% | 1,005 | $109K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 852 | $108K |
| 94729 | <1% | 3,220 | $106K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 2,986 | $103K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 941 | $100K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 519 | $100K |
| 73630 | <1% | 10,700 | $99K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,434 | $97K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 124 | $91K |
| 70496 | <1% | 1,743 | $91K | |
| 76801 | <1% | 996 | $90K | |
| 70498 | <1% | 1,786 | $89K | |
| 99205 | Prolong outpt/office vis | <1% | 586 | $89K |
| 99460 | <1% | 1,033 | $82K | |
| 73030 | <1% | 6,997 | $80K | |
| 97802 | <1% | 961 | $79K | |
| 73610 | <1% | 5,726 | $78K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,196 | $78K |
| 99443 | <1% | 1,031 | $77K | |
| 93971 | <1% | 4,682 | $75K | |
| 92134 | <1% | 4,416 | $75K | |
| 0002A | <1% | 2,360 | $72K | |
| 93970 | <1% | 2,966 | $71K | |
| 0001A | <1% | 2,550 | $67K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 3,437 | $66K |
| 95886 | <1% | 984 | $65K | |
| 94060 | <1% | 1,993 | $64K | |
| 31579 | <1% | 479 | $62K | |
| 76536 | <1% | 1,351 | $59K | |
| 95951 | <1% | 339 | $59K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 452 | $58K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,184 | $57K |
| 72110 | <1% | 2,204 | $55K | |
| 92133 | <1% | 3,015 | $55K | |
| 90961 | <1% | 573 | $54K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 442 | $50K |
| 93000 | <1% | 5,288 | $49K | |
| 70486 | <1% | 1,586 | $49K | |
| 92083 | <1% | 1,553 | $47K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,847 | $43K |
| 77014 | <1% | 1,545 | $42K | |
| 92557 | <1% | 1,728 | $41K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,960 | $41K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,288 | $40K |
| 94727 | <1% | 1,777 | $40K | |
| 31575 | <1% | 441 | $38K | |
| 96367 | <1% | 1,412 | $35K | |
| 73130 | <1% | 3,997 | $34K | |
| 74178 | <1% | 169 | $33K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 169 | $32K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 38 | $32K |
| 73502 | <1% | 2,828 | $31K | |
| 95800 | <1% | 292 | $31K | |
| 99221 | <1% | 377 | $30K | |
| 73562 | <1% | 2,868 | $28K | |
| 76770 | <1% | 1,178 | $28K | |
| 72141 | <1% | 267 | $28K | |
| 93880 | <1% | 739 | $27K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,685 | $27K |
| 99243 | <1% | 237 | $26K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 562 | $25K |
| 72100 | <1% | 2,113 | $25K | |
| 92567 | <1% | 2,637 | $25K | |
| 74018 | <1% | 4,793 | $24K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 153 | $24K |
| 99254 | <1% | 152 | $23K | |
| 11900 | <1% | 535 | $23K | |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 205 | $23K |
| 90962 | <1% | 258 | $22K | |
| 73110 | <1% | 1,855 | $22K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 542 | $22K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 175 | $22K |
| 91322 | <1% | 240 | $21K | |
| 69210 | <1% | 1,309 | $20K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,689 | $20K |
| 88341 | <1% | 337 | $20K | |
| 94726 | <1% | 500 | $20K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 170 | $19K |
| 59514 | <1% | 22 | $19K | |
| 94375 | <1% | 819 | $18K | |
| 92015 | Determination of refractive state | <1% | 2,385 | $18K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 630 | $17K |
| 95117 | <1% | 2,084 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,437 | $17K |
| 93015 | <1% | 304 | $16K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 328 | $16K |
| 72131 | <1% | 497 | $16K | |
| 81002 | <1% | 1,818 | $16K | |
| 77080 | <1% | 1,200 | $15K | |
| 11721 | <1% | 1,081 | $15K | |
| 93308 | <1% | 891 | $15K | |
| 64483 | <1% | 102 | $15K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 44 | $15K |
| 76820 | <1% | 365 | $15K | |
| 73560 | <1% | 1,172 | $15K | |
| 76775 | <1% | 691 | $14K | |
| 92250 | <1% | 538 | $14K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 16 | $14K |
| 86077 | <1% | 467 | $14K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 890 | $13K |
| 94200 | <1% | 1,122 | $13K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 480 | $12K |
| 19083 | <1% | 105 | $12K | |
| 99349 | <1% | 220 | $12K | |
| 46600 | <1% | 182 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,989 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 893 | $11K |
| 73590 | <1% | 1,251 | $10K | |
| 74174 | <1% | 158 | $10K | |
| 95813 | <1% | 84 | $10K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 255 | $10K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,161 | $10K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,382 | $10K |
| 81003 | <1% | 8,549 | $10K | |
| 95819 | <1% | 78 | $9K | |
| 93296 | <1% | 990 | $9K | |
| 92025 | <1% | 484 | $9K | |
| 99219 | <1% | 108 | $9K | |
| 93975 | <1% | 183 | $9K | |
| 76641 | <1% | 228 | $9K | |
| 88112 | <1% | 520 | $9K | |
| 0003A | <1% | 390 | $9K | |
| 72128 | <1% | 254 | $9K | |
| 92020 | <1% | 835 | $8K | |
| 77427 | <1% | 62 | $8K | |
| 72197 | <1% | 64 | $8K | |
| 92504 | <1% | 466 | $8K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 162 | $8K |
| 93295 | <1% | 328 | $8K | |
| T2022 | Case management, per month | <1% | 344 | $8K |
| 72040 | <1% | 562 | $7K | |
| 90480 | <1% | 241 | $7K | |
| 95012 | <1% | 585 | $7K | |
| 99292 | <1% | 149 | $7K | |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | <1% | 27 | $6K |
| 90674 | <1% | 266 | $6K | |
| 90688 | <1% | 562 | $6K | |
| 99385 | <1% | 44 | $5K | |
| 54150 | <1% | 60 | $5K | |
| 88304 | <1% | 480 | $5K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 54 | $5K |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 65 | $5K |
| 51798 | <1% | 1,172 | $5K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 224 | $5K |
| 96415 | <1% | 181 | $4K | |
| 70544 | <1% | 234 | $4K | |
| 88312 | <1% | 89 | $4K | |
| 99152 | <1% | 382 | $4K | |
| 99253 | <1% | 55 | $4K | |
| 96417 | <1% | 61 | $4K | |
| 00811 | <1% | 102 | $4K | |
| 99235 | <1% | 27 | $3K | |
| 72050 | <1% | 159 | $3K | |
| 81025 | <1% | 531 | $3K | |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 34 | $3K |
| 99201 | <1% | 84 | $3K | |
| 11104 | <1% | 38 | $3K | |
| 93922 | <1% | 53 | $3K | |
| 51705 | <1% | 45 | $3K | |
| 70491 | <1% | 38 | $3K | |
| 90686 | <1% | 202 | $3K | |
| 88141 | <1% | 111 | $3K | |
| 88311 | <1% | 309 | $3K | |
| 72170 | <1% | 235 | $2K | |
| 93248 | <1% | 166 | $2K | |
| 73552 | <1% | 319 | $2K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 43 | $2K |
| 95806 | <1% | 30 | $2K | |
| 99386 | <1% | 16 | $2K | |
| 88173 | <1% | 38 | $2K | |
| 99220 | <1% | 16 | $2K | |
| 64493 | <1% | 30 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 117 | $2K |
| 11981 | <1% | 18 | $2K | |
| 74230 | <1% | 193 | $2K | |
| 00840 | <1% | 12 | $2K | |
| 97597 | <1% | 169 | $2K | |
| 99255 | <1% | 14 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 13 | $2K |
| 98968 | <1% | 49 | $2K | |
| 76818 | <1% | 18 | $2K | |
| 73221 | <1% | 41 | $2K | |
| 93244 | <1% | 130 | $2K | |
| 84165 | <1% | 183 | $2K | |
| 11730 | <1% | 46 | $2K | |
| 73080 | <1% | 206 | $2K | |
| 92060 | <1% | 43 | $2K | |
| 90715 | <1% | 68 | $2K | |
| 20553 | <1% | 64 | $2K | |
| 52000 | <1% | 17 | $2K | |
| 94010 | <1% | 74 | $1K | |
| 20550 | <1% | 44 | $1K | |
| 11720 | <1% | 163 | $1K | |
| 96900 | <1% | 141 | $1K | |
| 58301 | <1% | 15 | $1K | |
| 99406 | <1% | 136 | $1K | |
| 71271 | <1% | 43 | $1K | |
| 75574 | <1% | 26 | $1K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 34 | $1K |
| 92511 | <1% | 12 | $1K | |
| 93242 | <1% | 123 | $1K | |
| 99442 | <1% | 54 | $1K | |
| 82962 | <1% | 3,758 | $1K | |
| 51741 | <1% | 193 | $1K | |
| 99252 | <1% | 16 | $1K | |
| 73522 | <1% | 54 | $963.87 | |
| 11056 | <1% | 28 | $957.78 | |
| 73090 | <1% | 143 | $926.54 | |
| 10060 | <1% | 17 | $917.32 | |
| 76942 | <1% | 32 | $892.31 | |
| 82803 | <1% | 80 | $857.85 | |
| 93246 | <1% | 97 | $827.05 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 90 | $821.39 |
| 11102 | <1% | 12 | $815.68 | |
| 58300 | <1% | 12 | $785.19 | |
| 78582 | <1% | 13 | $773.91 | |
| 94664 | <1% | 92 | $768.33 | |
| 0031A | <1% | 18 | $721.10 | |
| 90661 | <1% | 37 | $704.09 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 42 | $620.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 852 | $590.02 |
| 36415 | Collection of venous blood by venipuncture | <1% | 432 | $584.83 |
| 93297 | <1% | 48 | $527.99 | |
| 98967 | <1% | 20 | $502.00 | |
| 64494 | <1% | 30 | $498.23 | |
| 76857 | <1% | 28 | $495.12 | |
| 00731 | <1% | 14 | $479.55 | |
| 92136 | <1% | 32 | $472.26 | |
| 76514 | <1% | 91 | $472.21 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 91 | $412.00 |
| 93227 | <1% | 15 | $334.60 | |
| 93356 | <1% | 15 | $308.99 | |
| 93225 | <1% | 12 | $304.68 | |
| 76937 | <1% | 44 | $298.77 | |
| 76604 | <1% | 15 | $263.80 | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 14 | $255.86 |
| 92225 | <1% | 38 | $253.60 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $243.12 |
| 90694 | <1% | 47 | $229.36 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 303 | $226.53 |
| 93290 | <1% | 13 | $204.96 | |
| 84153 | <1% | 243 | $188.37 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 25 | $184.87 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 580 | $171.80 |
| 86580 | <1% | 17 | $141.95 | |
| 93016 | <1% | 12 | $136.72 | |
| 87210 | <1% | 27 | $121.16 | |
| 87220 | <1% | 27 | $109.72 | |
| 93018 | <1% | 12 | $94.52 | |
| 74019 | <1% | 13 | $93.11 | |
| 92226 | <1% | 46 | $92.56 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 14 | $90.30 |
| 73060 | <1% | 18 | $78.27 | |
| 96402 | <1% | 12 | $75.59 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 75 | $72.02 |
| 84155 | <1% | 29 | $68.28 | |
| 93321 | <1% | 20 | $64.81 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 50 | $63.30 |
| 83986 | <1% | 13 | $46.02 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12 | $41.51 |
| 93325 | <1% | 22 | $30.86 | |
| G0008 | Administration of influenza virus vaccine | <1% | 189 | $20.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 19 | $17.60 |
| 0124A | <1% | 43 | $14.01 | |
| 85610 | <1% | 28 | $8.62 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 25 | $7.83 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 25 | $3.41 |
| 77061 | 0% | 68 | $0.00 | |
| 36600 | 0% | 78 | $0.00 | |
| 99072 | 0% | 50 | $0.00 | |
| 77062 | 0% | 622 | $0.00 | |
| 90966 | 0% | 39 | $0.00 | |
| 91300 | 0% | 423 | $0.00 | |
| 99423 | 0% | 30 | $0.00 | |
| 36416 | 0% | 206 | $0.00 | |
| 0011A | 0% | 13 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBADGER, STEPHEN (CHIEF EXECUTIVE OFFICER)